1222800-79-4 (Ml-324,ML324)

N-(3-(二甲氨基)丙基)-4-(8-羟基喹啉-6-基)苯甲酰胺;ML324 抑制剂;

Ml-324;ML234;ML324;N-(3-(Dimethylamino)propyl)-4-(8-hydroxyquinolin-6-yl)benzamide;N-[3-(Dimethylamino)propyl]-4-(8-hydroxy-6-quinolinyl)benzamide;N-[3-(dimethylamino)propyl]-4-(8-hydroxyquinolin-6-yl)benzamide;MLS002391556;SMR001355524;MLS004685729;GTPL9584;BDBM79334;cid_44143208;BCP14395;s7296;3882AH;ML324, >=98% (HPLC);SMR003457050;AK316555;NCGC00183808-01;N-[3-(dimethylamino)propyl]-4-(8-oxidanylquinolin-6-yl)benzamide;2,2,2-tris(fluoranyl)ethanoic acid;NCGC00183808;1222800-79-4;GLXC-03280;SCHEMBL14937894;AS-72027;ML-324?;CS-3993;J-690072;N-[3-(dimethylamino)propyl]-4-(8-hydroxyquinolin-6-yl)benzamide;2,2,2-trifluoroacetic acid;AC-32787;Benzamide, N-[3-(dimethylamino)propyl]-4-(8-hydroxy-6-quinolinyl)-;MFCD28053518;NCGC00183808-18;NCGC00183808-06;NCGC00183808-03;CHEMBL1398529;ML 324;MMV1580488;NCGC00183808-12;N-[3-(dimethylamino)propyl]-4-(8-hydroxy-6-quinolinyl)-benzamide;5-[4-(Isopropylsulfonyl)phenyl]-3-(3-{4-[(methylamino)methyl]phenyl}-1,2-oxazol-5-yl)-2-pyrazinamine;AKOS027323940;HY-12725;XYB80079;CCG-268027;N-[3-(dimethylamino)propyl]-4-(8-hydroxy-6-quinolinyl)benzamide;2,2,2-trifluoroacetic acid;NCGC00183808-17;EX-A554;DA-47097;BRD-K25611237-001-02-1;N-[3-(dimethylamino)propyl]-4-(8-hydroxy-6-quinolyl)benzamide;2,2,2-trifluoroacetic acid;NCGC00183808-01; N-[3-(Dimethylamino)propyl]-4-(8-hydroxy-6-quinolinyl)-benzamide;ML-234;NCGC00183808-02;

MFCD28053518

QDBVSOZTVKXUES-UHFFFAOYSA-N

1S/C21H23N3O2/c1-24(2)12-4-11-23-21(26)16-8-6-15(7-9-16)18-13-17-5-3-10-22-20(17)19(25)14-18/h3,5-10,13-14,25H,4,11-12H2,1-2H3,(H,23,26)

O=C(C1C([H])=C([H])C(=C([H])C=1[H])C1=C([H])C(=C2C(C([H])=C([H])C([H])=N2)=C1[H])O[H])N([H])C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H]